Vectorial ligand transport through mammalian choroid plexus.
In the last decade, there has been substantial progress in understanding vectorial ligand transport through rodent and human choroid plexus (CP), the locus of the blood-CSF interface. In this Review, we enumerate the experimental data required to establish vectorial transport through CP and describe transporters involved in vectorial transport across CP. We also note how these transporters differ from those at the blood-brain barrier. The ligand (substrate) examples presented are methyltetrahydrofolate, methotrexate, leukotriene C(4), nucleosides, thiamine monophosphate, prostaglandins, and digoxin. Our focus is on more definitive experiments, including animal and human transporter "knock-outs." Finally, we discuss the neurochemical implications of vectorial transport through CP and the clinical implications of transporter polymorphisms and knockouts. Examples include descriptions of how vectorial transport through the CP for several micronutrients (e.g., methyltetrahydrofolate) nourishes the brain and how knowledge of CP vectorial transport can lead to important treatments.
Spector
Reynold
R
Department of Medicine, Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.
Johanson
Conrad E
CE
D000818:Animals; D001692:Biological Transport; D001812:Blood-Brain Barrier / Q000378:metabolism*; D002831:Choroid Plexus / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D026901:Membrane Transport Proteins / Q000378:metabolism*; D004364:Pharmaceutical Preparations / Q000097:blood* / Q000134:cerebrospinal fluid*; D013379:Substrate Specificity
D008024:Ligands; D026901:Membrane Transport Proteins; D004364:Pharmaceutical Preparations
J Neurochem. 1986 Jun;46(6):1725-31
3517230
Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):283-6
8990200
Neuropediatrics. 1999 Feb;30(1):5-7
10222453
J Histochem Cytochem. 1999 Oct;47(10):1255-64
10490454
J Biol Chem. 2001 Jan 26;276(4):2914-27
11032837
Drug Metab Dispos. 2003 Nov;31(11):1337-45
14570765
Cancer Res. 2002 Jun 1;62(11):3144-50
12036927
Cerebrospinal Fluid Res. 2008 Mar 04;5:5
18318891
Arch Biochem Biophys. 1982 Jul;216(2):693-703
7114856
J Neurochem. 2007 Oct;103(2):425-38
17645457
Am J Hum Genet. 2009 Sep;85(3):354-63
19732866
Biochemistry. 2005 Jan 11;44(1):340-51
15628876
J Appl Physiol (1985). 2006 Apr;100(4):1392-9
16322371
Pflugers Arch. 2001 Nov;443(2):188-95
11713643
Biochim Biophys Acta. 2003 Jan 10;1609(1):1-18
12507753
Pflugers Arch. 2004 Feb;447(5):735-43
12838422
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9244-9
12835412
Mol Interv. 2009 Jun;9(3):136-45
19592674
J Comp Neurol. 2008 Oct 10;510(5):497-507
18680196
J Neurochem. 2009 Oct;111(2):315-20
19686385
Adv Drug Deliv Rev. 2004 Oct 14;56(12):1765-91
15381333
Mol Cell Biol. 2004 Sep;24(17):7612-21
15314169
Am J Physiol Renal Physiol. 2003 Dec;285(6):F1188-97
14631946
Cancer Treat Rep. 1976 Jul;60(7):913-6
1009521
Biochim Biophys Acta. 1979 Jan 5;550(1):110-9
216402
Am J Physiol Renal Physiol. 2002 May;282(5):F877-85
11934698
Neurochem Res. 1983 Oct;8(10):1307-20
6656989
J Pharmacol Exp Ther. 1974 Jan;188(1):55-65
4809276
Cerebrospinal Fluid Res. 2008 May 14;5:10
18479516
Arch Biochem Biophys. 1981 Apr 15;208(1):87-94
7259191
Biochem Pharmacol. 1986 Sep 1;35(17):2849-53
3741476
Pharm Res. 2007 May;24(5):859-67
17372683
Biochem Biophys Res Commun. 2003 Aug 8;307(4):987-90
12878209
J Clin Invest. 1980 Oct;66(4):821-31
7419721
J Neurochem. 2010 Jan;112(1):13-23
19860860
Science. 1975 Feb 14;187(4176):540-2
1167256
Science. 1995 May 12;268(5212):866-9
7754369
J Clin Invest. 2000 Feb;105(3):279-85
10675353
Trends Pharmacol Sci. 2008 Apr;29(4):200-7
18353444